Protective effects of Zhuyeqing liquor on the immune function of normal and immunosuppressed mice in vivo

BMC Complementary and Alternative Medicine

Jin-hui Wang³  Hang-yu Wang³  Li-juan An¹  Xiao-wei Du¹  Fu-zhou Sun²  Ying Han¹  Jian Huang²  Guo-yu Li³  Hong-ying Gao² 

[1] Shanxi Xinghuacun Fen Jiu Group Co. Ltd, Shanxi 450000, P.R. China;School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, P.R. China;School of Pharmacy, Shihezi University, Shihezi 832002, P.R. China

关键词: Cyclophosphamide;    Antioxidant effects;    Immune function;    Zhuyeqing liquor;   

Others  :  1220938
DOI  :  10.1186/1472-6882-13-252

 received in 2013-03-26, accepted in 2013-09-19,  发布年份 2013

【 摘 要 】

Background

Zhuyeqing Liquor (ZYQL), a well-known Chinese traditional health liquor, has various biological properties, including anti-oxidant, anti-inflammatory, immunoenhancement and cardiovascular protective effects.

Methods

The protective effects of Zhuyeqing Liquor (ZYQL) on the immune function was investigated in vivo in normal healthy mice and immunosuppressed mice treated with Cyclophosphamide (Cy, 100 mg/kg) by intraperitoneal injection on days 4, 8 and 12. ZYQL (100, 200 and 400 mg/kg) was administered via gavage daily for 14 days. The phagocytotic function of mononuclear phagocytic system was detected with carbon clearance methods, the levels of interleukin-6 (IL-6) and interferon-gamma (IFN-γ) in serum were detected with Enzyme linked immunosorbent assay (ELISA). Immune organs were weighed and organ indexes (organ weight/body weight) of thymus and spleen were calculated. Meanwhile, the activity of lysozyme (LSZ) in serum and the activity of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) in spleen tissue were measured.

Results

ZYQL significantly upgrades the K value for clearance of carbon particles in normal mice treated with ZYQL (400 mg/kg) and immunosuppressed mice treated with ZYQL (100, 200 and 400 mg/kg) together with Cy (100 mg/kg) in vivo. The treatment of ZYQL (100, 200 and 400 mg/kg) effectively increased the activity of serum lysozyme as well as promoted the serum levels of IL-6 and IFN-γ in normal mice and immunosuppressed mice. Furthermore, ZYQL (100, 200 and 400 mg/kg) had an antioxidant effects in immune system by enhancing the antioxidant enzyme activity of SOD, CAT and GSH-Px in vivo. In addition, ZYQL (100, 200 and 400 mg/kg) effectively elevated the Cy-induced decreased organ index (thymus and spleen).

Conclusions

The present work shows that the dose-dependent administration of ZYQL is capable of influencing immune responses, which implying that its valuable functional health may be attributed partly to its protective effects for the immune function.

【 授权许可】

   
2013 Gao et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Li ZY, Liu HB: Fragrant zhuyeqing liquor. Liquor making 2010, 37:79-80.
• [2]Wasser SP: Medicinal mushrooms as a source of anti-tumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 2002, 60:258-274.
• [3]Paulsen BS: Plant polysaccharides with immunostimulatory activities. Curr Org Chem 2001, 5:939-950.
• [4]Kayser O, Masihi KN, Kiderlen AF: Natural products and synthetic compounds as immunomodulators. Expert Rev Anti Infect Ther 2003, 1:319-335.
• [5]Cheng AW, Wan FC, Wang JQ, Jin ZY, Xu XM: Macrophage immunomodulatory activity of polysaccharides isolated from Glycyrrhiza uralensis Fisch. Int Immunopharmacol 2008, 8:43-50.
• [6]Yang TH, Jia M, Meng J, Wu H, Mei QB: Immunomodulatory activity of polysaccharide isolated from Angelica sinensis. Int J Biol Macromol 2006, 39:179-184.
• [7]Tang LL, Xue LL, Ding XL: The Inhibitory Effect of Bamboo-leaf-polysaccharide on Implanted Sarcoma 180 Tumor. Journal of wuxi university of light industry 1998, 17:62-65.
• [8]Kang KW, Choi JS: Enhanced bioavailability of paclitaxel by bamboo concentrate administration. Arch Pharm Res 2005, 28:469-475.
• [9]Ando H, Ohba H, Sakaki T, Takamine K, Kamino Y, Moriwaki S, Bakalova R, Uemura Y, Hatate Y: Hot-compressed-water decomposed products from bamboo manifest a selective cytotoxicity against acute lymphoblastec leukemia cells. Toxicol In Vitro 2004, 18:765-767.
• [10]Chen Y, Duan JA, Qian DW, Guo JM, Song BS, Yang M: Assessment and comparison of immunoregulatory activity of four hydrosoluble fractions of Angelica sinensis in vitro on the peritoneal macrophages in ICR mice. Int Immunopharmacol 2010, 10:422-430.
• [11]Bistoni F, Baccarini M, Blasi E, Marconi P, Puccetti P, Garaci E: Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice. Infect Immun 1983, 40:46-55.
• [12]Mitsuoka A, Baba M, Morikawa S: Enhancement of delayed hypersensitivity by depletion of suppressor T-cells with cyclophosmide in mice. Nature 1976, 262:77-78.
• [13]Turk JL, Parker D: The effect of cyclophosphamide on the immune response. J Immunopharmacol 1979, 1:127-137.
• [14]Seldrade MK, Daniels MJ, Hu PC, Miller FJ, Graham JA: Effects of immunosuppression with cyclophosphamide on acute murine cytomegalovirus infection and virus-augmented natural killer cell activity. Infect Immun 1982, 38:1046-1055.
• [15]Hickman-Davis JM, Lindsey JR, Matalon S: Cyclophosphamide decreases nitrotyrosine formation and inhibits nitric oxide production by alveolar macrophages in mycoplasmosis. Infect Immun 2001, 69:6401-6410.
• [16]Kermanl AV, Moll T, Cho BR, Davis WC, Lu YS: Effect of cyclophosphamide on the response of chickens to a virulent strain of Marek’s disease virus. Infect Immun 1976, 12:1058-1064.
• [17]Dollery C: Therapeutic Drugs. Edinburgh: Churchill Livingstone; 1999:C349-C354.
• [18]Patel JM: Metabolism and pulmonary toxicity of cyclophosphamide. Pharmacol Ther 1990, 47:137-146.
• [19]Shand FL: The immunopharmacology of cyclophosphamide. Int J Immunopharmacol 1979, 1:165-171.
• [20]Kumari J, Sahoo PK: Effects of cyclophosphamide on the immune system and disease resistance of Asian catfish Clarias batrachus. Fish Shellfish Immunol 2005, 19:307-316.
• [21]Beauchamp C, Fridovich I: Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971, 44:276-287.
• [22]Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG: Selenium: biochemical role as a component of glutathione peroxidase. Science 1973, 179:588-590.
• [23]Aebi H: Catalase in vitro. Methods Enzymol 1984, 105:121-126.
• [24]Struck RF, Kari P, Kalin J, Montgomery JA, Marinello AJ, Love J, Bansal SK, Gurtoo HL: Metabolism of cyclophosphamide by purified cytochrome P-450 from microsomes of phenobarbital-treated rats. Biochem Biophys Res Commun 1984, 120:390-396.
• [25]Lee KY, Jeon YJ: Macrophage activation by polysaccharide isolated from Astragalus membranaceus. Int Immunopharmacol 2005, 5:1225-1233.
• [26]Hyang SC, Eun HC, HyUn JK, Chang WC, Sung JH: In vitro and in vivo antitumor activities of water extracts from agancus blazei murill. Food Sci. Biotechnol 2001, 10:335-340.
• [27]Yoo HJ, Byun HJ, Kim BR, Lee KH, Park SY, Rho SB: DAPk1 inhibits NF-κB activation through TNF-α and INF-γ-induced apoptosis. Cell Signal 2012, 24:1471-1477.
• [28]Matsuda T, Suematsu S, Kawano M, Yoshizaki K, Tang B, Tanabe O, Nakajima T, Akira S, Hirano T, Kishimoto T: IL-6/BSF2 in normal and abnormal regulation of immune responses. Ann NY Acad Sci 1989, 557:466-476.
• [29]Dahlin D, Miwa G, Lu A, Nelson S: N-acetyl-p-bezoquinononeimine: a cytochrome p-450-dependent oxidation product of acetaminophen. Proc Natl Acad Sci 1984, 81:1327-1331.
• [30]Parmar D, Ahmed G, Kandakumar M, Katyare S: Mitochondrial ATPase: a target for Acetaminophen-induced hepatotoxicity. Eur J Pharmacol 1995, 293:225-229.